The clinical spectrum of Caspr2 antibody–associated disease

MLA

Peter Körtvelyessy, et al. The Clinical Spectrum of Caspr2 Antibody–associated Disease. Aug. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....43eb66c7a47e0a42704ebf3120ddcd5e&authtype=sso&custid=ns315887.

APA

Peter Körtvelyessy, Maarten J. Titulaer, Marco W.J. Schreurs, Peter A. E. Sillevis Smitt, Frank Leypoldt, Helena Ariño, Mar Petit-Pedrol, Josep Dalmau, Agnes van Sonderen, Klaus-Peter Wandinger, Eric Lancaster, Francesc Graus, & Paul W. Wirtz. (2016). The clinical spectrum of Caspr2 antibody–associated disease.

Chicago

Peter Körtvelyessy, Maarten J. Titulaer, Marco W.J. Schreurs, Peter A. E. Sillevis Smitt, Frank Leypoldt, Helena Ariño, Mar Petit-Pedrol, et al. 2016. “The Clinical Spectrum of Caspr2 Antibody–associated Disease,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....43eb66c7a47e0a42704ebf3120ddcd5e&authtype=sso&custid=ns315887.